Krystal Biotech (KRYS) EBITDA (2016 - 2026)
Krystal Biotech's EBITDA came in at $59.82 million for Q2 2026, up 47.0% from $40.7 million a year earlier and up 8.3% from the prior quarter.
Powered by 
Analysis
Krystal Biotech (KRYS) EBITDA (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Krystal Biotech reported EBITDA of $203.6 million, up 40.5% year-over-year; for FY2025, it came in at $167.02 million, up 132.8% from FY2024.
- Going back by year, EBITDA was $71.75 million in FY2024, -$105.89 million in FY2023, -$139.73 million in FY2022 and -$64.59 million in FY2021.
- The Q2 2026 figure represents the highest quarterly EBITDA in data going back to Q4 2016.
- Year-over-year, EBITDA has increased for five consecutive quarters, with growth averaging 212.1% over the last six quarters.
- Business Quant data shows KRYS's EBITDA at $55.21 million (Q1 2026), $45.79 million (Q4 2025) and $42.77 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Krystal Biotech | 9.98 Bn | 6.75 Bn | 112.79 Mn | 59.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.82 Mn |
| Mar 31, 2026 | 55.21 Mn |
| Dec 31, 2025 | 45.79 Mn |
| Sep 30, 2025 | 42.77 Mn |
| Jun 30, 2025 | 40.70 Mn |
| Mar 31, 2025 | 37.66 Mn |
| Dec 31, 2024 | 42.77 Mn |
| Sep 30, 2024 | 23.77 Mn |
| Jun 30, 2024 | 10.37 Mn |
| Mar 31, 2024 | -5.26 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | -25.17 Mn |
| Jun 30, 2023 | -37.01 Mn |
| Mar 31, 2023 | -48.12 Mn |
| Dec 31, 2022 | -33.68 Mn |
| Sep 30, 2022 | -30.48 Mn |
| Jun 30, 2022 | -27.78 Mn |
| Mar 31, 2022 | -49.21 Mn |
| Dec 31, 2021 | -21.09 Mn |
| Sep 30, 2021 | -14.87 Mn |
API Access
Krystal Biotech EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=KRYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "KRYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=KRYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();